相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interaction of the anticancer gallium(III) complexes of 8-hydroxyquinoline and maltol with human serum proteins
Eva A. Enyedy et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2015)
Modeling human carcinomas: Physiologically relevant 3D models to improve anti-cancer drug development
Christine Unger et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46
Ute Jungwirth et al.
MOLECULAR CANCER THERAPEUTICS (2014)
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl et al.
CHEMICAL SCIENCE (2014)
Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D
Jennifer Laurent et al.
BMC CANCER (2013)
The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo
Petra Heffeter et al.
EUROPEAN JOURNAL OF CANCER (2013)
Characterization of the binding sites of the anticancer ruthenium(III) complexes KP1019 and KP1339 on human serum albumin via competition studies
Orsolya Doemoetoer et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2013)
Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response
Anika Nagelkerke et al.
BREAST CANCER RESEARCH (2013)
Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation
Maria Vinci et al.
BMC BIOLOGY (2012)
DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination
Christopher Korch et al.
GYNECOLOGIC ONCOLOGY (2012)
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Geeta Mehta et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Molecular mechanisms mediating metastasis of hypoxic breast cancer cells
Gregg L. Semenza
TRENDS IN MOLECULAR MEDICINE (2012)
Modeling Colon Adenocarcinomas in Vitro A 3D Co-Culture System Induces Cancer-Relevant Pathways upon Tumor Cell and Stromal Fibroblast Interaction
Helmut Dolznig et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic Cancer
Qing Chang et al.
CANCER RESEARCH (2011)
LC- and CZE-ICP-MS approaches for the in vivo analysis of the anticancer drug candidate sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] (KP1339) in mouse plasma
Anna K. Bytzek et al.
METALLOMICS (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Multicellular tumor spheroids: An underestimated tool is catching up again
Franziska Hirschhaeuser et al.
JOURNAL OF BIOTECHNOLOGY (2010)
{(1R,2R,4R)-4-Methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): A Novel Enantiomerically Pure Oxaliplatin Derivative Showing Improved Anticancer Activity in Vivo
Sergey A. Abramkin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells
D. L. Roberts et al.
BRITISH JOURNAL OF CANCER (2009)
The gallium complex KP46 exerts strong activity against primary explanted melanoma cells and induces apoptosis in melanoma cell lines
Seied Mojtaba Valiahdi et al.
MELANOMA RESEARCH (2009)
HYPOXIA AND METABOLISM SERIES - TIMELINE The impact of O2 availability on human cancer
Jessica A. Bertout et al.
NATURE REVIEWS CANCER (2008)
Experimental anti-tumor therapy in 3-D: Spheroids - old hat or new challenge?
Juergen Friedrich et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2007)
Hypoxia-inducible factor-1 (HIF-1)
Qingdong Ke et al.
MOLECULAR PHARMACOLOGY (2006)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772;: FFC24)
P Heffeter et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Hypoxia-mediated down-regulation of bid and bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance
JT Erler et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
AM Shannon et al.
CANCER TREATMENT REVIEWS (2003)
Alpha-smooth muscle actin expression upregulates fibroblast contractile activity
B Hinz et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies
LA Hazlehurst et al.
CANCER AND METASTASIS REVIEWS (2001)
Multicellular resistance: a paradigm for clinical resistance?
B Desoize et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2000)
分享论文
